Biden Administration Plans to Regulate Nicotine in Tobacco Products

Jun.22.2022
Biden Administration Plans to Regulate Nicotine in Tobacco Products
The Biden administration plans to set rules limiting nicotine levels in tobacco products to reduce addiction and prevent cancer.

On Tuesday, the White House Office of Management and Budget announced that the Biden administration plans to propose a rule setting a maximum nicotine level for cigarettes and other tobacco products in an effort to reduce their addictiveness.

 

According to a document released by the White House Office of Budget, this regulation is expected to be established in May 2023 with the aim of making it easier for tobacco users to quit and helping prevent young people from becoming regular smokers.

 

This proposal comes at a time when the Biden administration is redoubling its efforts to combat deaths related to cancer.

 

Earlier this year, the government announced plans to reduce cancer mortality rates by at least 50% over the next 25 years.

 

Nicotine is an addictive substance found in tobacco. Tobacco products also contain several harmful chemicals, many of which can lead to cancer.

 

According to data from the Food and Drug Administration (FDA), tobacco use costs nearly $300 billion in direct medical and productivity losses every year.

 

Smoking and exposure to tobacco smoke in the United States result in approximately 480,000 premature deaths each year, according to health experts who have long identified this as the leading cause of preventable death.

 

According to data from the Centers for Disease Control and Prevention in the United States, over 7,300 non-smokers die each year from lung cancer caused by secondhand smoke. Currently, the smoking rate among American adults is 12.5%.

 

In April of this year, the US Food and Drug Administration released a long-awaited proposal to ban mint-flavored cigarettes and flavored cigars, which is seen as a major victory for anti-smoking advocates.

 

Source: Reuters

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Denver to Hold Referendum on Flavored Tobacco Sales Ban; If Approved, Enforcement Begins in 2026
Denver to Hold Referendum on Flavored Tobacco Sales Ban; If Approved, Enforcement Begins in 2026
A referendum to be held on November 4 will determine whether Denver retains its ban on the sale of flavored tobacco/nicotine products. Campaign finance records show that, as of the end of August, the side seeking to repeal the ban had raised $410,000, significantly more than the pro-ban side (about $245,000). The ban took effect in March 2025, but the city had planned to begin enforcement on January 2026; if the referendum overturns the ban, enforcement will not proceed.
Sep.25 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Product | HQD launches the new HQD GO in the U.S., featuring three power levels and a ~$30 price tag.
Product | HQD launches the new HQD GO in the U.S., featuring three power levels and a ~$30 price tag.
HQD has listed the disposable HQD GO on its official site and U.S. channels. The device touts 35,000 puffs, three power levels with adjustable airflow, and a 30 mg/ml nicotine strength. On U.S. retail websites, it’s priced at about $29.99.
Oct.24 by 2FIRSTS.ai
Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October
Tuscaloosa, Alabama, plans to impose an e-cigarette tax before a state law takes effect in October
The Tuscaloosa, Alabama, City Council is considering imposing a local tax on e-cigarette products to meet a state bill deadline. Alabama Act 2025-377, signed into law in May, plans to impose a $0.10 per milliliter state excise tax on e-cigarette products starting in October.
Sep.25 by 2FIRSTS.ai
Police Action: Two Shops in Derbyshire Town Sealed for Selling Illegal Tobacco and E-Cigarettes
Police Action: Two Shops in Derbyshire Town Sealed for Selling Illegal Tobacco and E-Cigarettes
Police in a small town in Derbyshire, England, seized a large amount of illegal tobacco and e-cigarettes and closed down illegal stores with a market value of thousands of pounds. Police urged the public to report illegal activities.
Sep.17 by 2FIRSTS.ai
British American Tobacco to Open glo™ Ginza Flagship Store in Tokyo on October 18
British American Tobacco to Open glo™ Ginza Flagship Store in Tokyo on October 18
BAT Japan to open two-storey glo™ Ginza flagship on Oct 18, 2025; sales + members’ lounge, promos; near IQOS.
Oct.11 by 2FIRSTS.ai